HonCode

Go Back   HER2 Support Group Forums > her2group
Register Gallery FAQ Members List Calendar Today's Posts

Reply
 
Thread Tools Display Modes
Old 03-20-2011, 09:24 PM   #1
Lani
Senior Member
 
Join Date: Mar 2006
Posts: 4,783
Thumbs up talk at upcoming 2011 AACR annual meeting--her2 bc prevention..in mice

only brief treatment needed during just the right time, it seems!!!

2838 Brief exposure to gefitinib/Iressa during premalignant risk window provides lifelong protection from mammary tumor development in MMTV-erbB-2 transgenic mice. Zhikun Ma, Yunbo Jiang, Shihe Yang, Stanley D. Kosanke, Xiaoshan Feng, XiaoHe Yang.
Lani is offline   Reply With Quote
Reply


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT -7. The time now is 01:42 AM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter